Elixir Associates reposted this
Headhunting Talented Individuals within Clinical Operations & Clinical Development for growing organizations across the US & Europe
🚀 The Hottest Cancer Drug Launch of 2025? AbbVie is making waves in the oncology community with its investigational cancer drug, telisotuzumab-vedotin (Teliso-V). This c-Met-directed antibody-drug conjugate (ADC) for non-small cell lung cancer (NSCLC) is sparking a lot of excitement 📊✅ According to a recent ZoomRx survey, 55% of oncologists are already aware of Teliso-V. Even more impressive, nearly one-quarter of them named it one of the three most exciting cancer prospects in development. With AbbVie planning to file for accelerated approval later this year, Teliso-V could be on the market by 2025. This could prove game-changing for NSCLC treatment 🤞 #CancerTreatment #Oncology #ClinicalResearch #ClinicalTrials #NSCLC #AbbVie #LifeScience #ElixirAssociates #StaffingPartner